CALISTOGA PHARMACEUTICALS

calistoga-pharmaceuticals-logo

Calistoga Pharmaceuticals, Inc. is the leader in developing innovative oral medicines targeting selected isoforms of the PI3 kinase pathway to improve the health of patients with cancer and inflammatory diseases. The PI3K pathway is a critical cellular pathway involved in cell survival and immune cell activation. Calistoga Pharmaceuticals' small-molecule therapeutic candidates inhibit specific isoforms of the PI3K pathway, providing a targeted treatment approach designed to maximize clinical... outcome and limit unwanted side effects. Calistoga Pharmaceuticals' lead product, CAL-101, an oral delta-isoform selective PI3K inhibitor, has demonstrated promising clinical responses in patients with B-cell malignancies and is currently being evaluated in multiple clinical trials. In addition to CAL-101, Calistoga Pharmaceuticals' product development pipeline includes other selective PI3K inhibitors in early preclinical development or ready for initial clinical trials in patients with cancer or inflammatory diseases.

#SimilarOrganizations #People #Financial #Website #More

CALISTOGA PHARMACEUTICALS

Social Links:

Industry:
Alternative Medicine Biotechnology Medical

Founded:
2006-01-01

Address:
Seattle, Washington, United States

Country:
United States

Website Url:
http://www.calistogapharma.com

Total Employee:
1+

Status:
Active

Contact:
07804443213

Total Funding:
97.2 M USD

Technology used in webpage:
SPF Mobile Non Scaleable Content Amazon Amazon Virginia Region NameBright Citrix NetScaler StatCounter


Similar Organizations

epicyte-pharmaceuticals-logo

Epicyte Pharmaceuticals

Epicyte Pharmaceutical is focused on development therapeutic monoclonal antibodies for cancer, infectious and inflammatory diseases.

kindex-pharmaceuticals-logo

KinDex Pharmaceuticals

KinDex Pharmaceuticals is a developer of novel therapeutics used to help patients suffering from metabolic disorders.

Current Employees Featured

michael-gallatin_image

Michael Gallatin
Michael Gallatin President @ Calistoga Pharmaceuticals
President

james-topper_image

James Topper
James Topper Co-Founder @ Calistoga Pharmaceuticals
Co-Founder

neill-giese_image

Neill Giese
Neill Giese CSO @ Calistoga Pharmaceuticals
CSO
2006-01-01

Founder


james-topper_image

James Topper

Investors List

latterell-venture-partners_image

Latterell Venture Partners

Latterell Venture Partners investment in Series C - Calistoga Pharmaceuticals

amgen-ventures_image

Amgen Ventures

Amgen Ventures investment in Series C - Calistoga Pharmaceuticals

alta-partners_image

Alta Partners

Alta Partners investment in Series C - Calistoga Pharmaceuticals

quogue-capital_image

Quogue Capital

Quogue Capital investment in Series C - Calistoga Pharmaceuticals

three-arch-partners_image

Three Arch Partners

Three Arch Partners investment in Series C - Calistoga Pharmaceuticals

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Series C - Calistoga Pharmaceuticals

alta-partners_image

Alta Partners

Alta Partners investment in Series B - Calistoga Pharmaceuticals

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Series B - Calistoga Pharmaceuticals

amgen-ventures_image

Amgen Ventures

Amgen Ventures investment in Series B - Calistoga Pharmaceuticals

three-arch-partners_image

Three Arch Partners

Three Arch Partners investment in Series B - Calistoga Pharmaceuticals

Official Site Inspections

http://www.calistogapharma.com

  • Host name: 172.67.152.202
  • IP address: 172.67.152.202
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Calistoga Pharmaceuticals"

Calistoga Pharmaceuticals - Crunchbase Company โ€ฆ

Calistoga Pharmaceuticals, Inc. is the leader in developing innovative oral medicines targeting selected isoforms of the PI3 kinase pathway to improve โ€ฆSee details»

Calistoga Pharmaceuticals Management Team | Org Chart

Calistoga Pharmaceuticals employs 12 employees. The Calistoga Pharmaceuticals management team includes Mike Gallatin (President), Neill Giese (Chief Scientific Officer), and Daryl Winter โ€ฆSee details»

Calistoga Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...

May 7, 2025 www.calistogapharma.com. Subsidiary Company | 2006 | Washington, United States | < 10 | www.calistogapharma.com. Last update 08 May 2025. Overview. Pipeline. โ€ฆSee details»

Calistoga Pharmaceuticals - Products, Competitors, Financials ...

Calistoga Pharmaceuticals is a biopharmaceutical company developing multiple compounds selectively targeting the PI3K pathway, a pathway known to be involved in certain cancers and โ€ฆSee details»

Team Site Traffic

When you join make sure you send a copy of your receipt to . Alright, now letโ€™s talk details. Gavinโ€™s training in the system shows you exactly how to build a thriving network marketing โ€ฆSee details»

Calistoga Pharmaceuticals - Ownership and Business Overview

Www.calistogapharma.com. Profile Investors (2) Analytics ... Calistoga is a privately held organization headquartered in Seattle. Company Summary. SECTOR. Life Science. โ€ฆSee details»

Calistoga Pharmaceuticals - Overview, Competitors, And ... - Ampliz

Calistoga Pharmaceuticals`s Overview, Revenue, Employee Size, Location For Free. Find Key Decision Makers Of Calistoga Pharmaceuticals Email, Phone, LinkedIn Profile.See details»

Calistoga Pharmaceuticals - LinkedIn

Calistoga Pharmaceuticals, Inc. is the leader in developing innovative oral medicines targeting selected isoforms of the PI3 kinase pathway to improve the health of patients with cancer and ...See details»

Calistoga Pharmaceuticals - PitchBook

Calistoga Pharmaceuticals General Information Description. Developer of medicines targeting selective isoforms of the PI3 kinase pathway to improve the health of patients with cancer, โ€ฆSee details»

Orphanet: CALISTOGA PHARMACEUTICALS, INC.

Dear Orphanet User, Your opinion is essential in improving the services offered by Orphanet. Your contribution to this survey is also indispensable for our funding agencies. Please could โ€ฆSee details»

Company Information - RocketReach

Calistoga Pharmaceuticals, Inc. is the leader in developing innovative oral medicines targeting selected isoforms of the PI3 kinase pathway to improve the health of patients with cancer and โ€ฆSee details»

Gilead Sciences to Acquire Calistoga Pharmaceuticals for $375 โ€ฆ

Feb 22, 2011 For more information, visit the companyโ€™s website at: www.calistogapharma.com. About Gilead Sciences. Gilead Sciences is a biopharmaceutical company that discovers, โ€ฆSee details»

Calistoga Pharmaceuticals - Company Info, Employees

View Calistoga pharmaceuticals calistogapharma.com location in 2101 4th ave, seattle, washington, 98121, united states, revenue, industry and description. Find related and similar โ€ฆSee details»

Calistoga Pharmaceuticals, Inc.: Drug pipelines, Patents, Clinical ...

Jul 16, 2023 Explore Calistoga Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 11 news, and 1 literature, Drug:Idelalisib, CAL-263.See details»

Calistoga Pharmaceuticals Overview | SignalHire Company Profile

Calistoga Pharmaceuticals, Inc. is the leader in developing innovative oral medicines targeting selected isoforms of the PI3 kinase pathway to improve the health of patients with cancer and โ€ฆSee details»

Calistoga Pharmaceuticals - Tech Company Profile - Gaebler.com โ€ฆ

Www.calistogapharma.com. Email Address [email protected] Company Background Information. Overview. Calistoga Pharmaceuticals, is developing a drug candidate acquired from Icos that โ€ฆSee details»

Calistoga Pharmaceuticals Raises $40 Million in Series C Financing

Jun 30, 2010 For more information, visit the Companyโ€™s website at: www.calistogapharma.com. CONTACT: Rathbun Communications, Inc. Julie Rathbun, 206-769-9219 [email protected]See details»

Calistoga Pharmaceuticals Appoints Carol G. Gallagher, Pharm. D., โ€ฆ

Oct 8, 2008 Calistoga Pharmaceuticals Appoints Carol G. Gallagher, Pharm. D., Chief Executive Officer SEATTLE--(BUSINESS WIRE)--October 8, 2008--Pharmaceuticals, Inc., a company โ€ฆSee details»

Gilead Sciences, Inc. to Acquire Calistoga Pharmaceuticals for $375 ...

Feb 22, 2011 FOSTER CITY, Calif. & SEATTLE--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) and Calistoga Pharmaceuticals, Inc., a privately-held biotechnology company โ€ฆSee details»

Ineffectiveness of Water Mist Spray to the upper body of healthy โ€ฆ

1 day ago The International Labour Organization estimated that 2.2% of total working hours and 80 million full-time jobs will be lost by 2030 even if the stringent control of CO 2 emissions in โ€ฆSee details»

linkstock.net © 2022. All rights reserved